Patent · US Active

Therapeutic dendrimers

US10314920B2 · kind B2 · utility

2Cited by
8References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 20, 2018
Grant dateJun 11, 2019
Priority date—
Expiry dateFeb 20, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08G83/003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are dendrimers of formula (I): and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions comprising the dendrimer of formula (I) and methods of using the same for treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.